🚀💸 Limited time offer: $49 for pro access to 1,000+ investors
Matt Zuga
HighCape Capital
Description
A growth equity firm that invests in companies that are commercializing high-margin life sciences products.
Email Address
Website
Investment stages
Series D
Series C
Interested in